ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Accounts Payable & Accrued Expense : $3.73 Mil (As of Jan. 2024)

View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Accounts Payable & Accrued Expense?

ImmunoPrecise Antibodies's quarterly accounts payable & accrued expense increased from Jul. 2023 ($3.00 Mil) to Oct. 2023 ($3.41 Mil) and increased from Oct. 2023 ($3.41 Mil) to Jan. 2024 ($3.73 Mil).

ImmunoPrecise Antibodies's annual accounts payable & accrued expense increased from Apr. 2021 ($2.78 Mil) to Apr. 2022 ($4.13 Mil) but then declined from Apr. 2022 ($4.13 Mil) to Apr. 2023 ($2.51 Mil).

ImmunoPrecise Antibodies Accounts Payable & Accrued Expense Historical Data

The historical data trend for ImmunoPrecise Antibodies's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Accounts Payable & Accrued Expense Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec13

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.21

1.26

2.78

4.13

2.51

ImmunoPrecise Antibodies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.28	2.51	3.00	3.41	3.73

ImmunoPrecise Antibodies Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

TQB:Germany

Address

3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8

Website

https://www.immunoprecise.com

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.